Detection of plasma hnRNP B1 mRNA, a new cancer biomarker, in lung cancer patients by quantitative real-time polymerase chain reaction
- 30 April 2005
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 48 (1), 77-83
- https://doi.org/10.1016/j.lungcan.2004.10.007
Abstract
No abstract availableKeywords
Funding Information
- Uehara Memorial Foundation
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 14 references indexed in Scilit:
- hnRNP B1 protein may be a possible prognostic factor in squamous cell carcinoma of the lungLung Cancer, 2003
- Detection and discrimination of preneoplastic and early stages of lung adenocarcinoma using hnRNP B1 combined with the cell cycle-related markers p16, cyclin D1, and Ki-67Lung Cancer, 2003
- Overexpression of heterogeneous nuclear ribonucleoprotein B1 in lymphoproliferative disorders: high expression in cells of follicular center origin.International Journal of Oncology, 2002
- RNA is more sensitive than DNA in identification of breast cancer patients bearing tumor nucleic acids in plasmaGenes, Chromosomes and Cancer, 2002
- Circulating RNA as a Tumor MarkerAnnals of the New York Academy of Sciences, 2001
- Heterogeneous Nuclear Ribonucleoprotein B1 Expressed in Esophageal Squamous Cell Carcinomas as a New Biomarker for DiagnosisJapanese Journal of Cancer Research, 2000
- Significance of Heterogeneous Nuclear Ribonucleoprotein B1 as a New Early Detection Marker for Oral Squamous Cell CarcinomaJapanese Journal of Cancer Research, 1999
- Purification and Characterization of a Protein That Permits Early Detection of Lung CancerPublished by Elsevier ,1996
- Conserved Structures and Diversity of Functions of RNA-Binding ProteinsScience, 1994
- Isolation and characterization of an RNA-proteolipid complex associated with the malignant state in humans.Proceedings of the National Academy of Sciences, 1985